Assay ID | Title | Year | Journal | Article |
AID1471421 | Antiproliferative activity against human HuH7 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471401 | Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471415 | Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471449 | Inhibition of firefly luciferase activity using luciferin substrate at 10 uM after 30 mins by luminescence assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471414 | Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID378025 | Cytotoxicity against human KB cells | 2006 | Journal of natural products, Jul, Volume: 69, Issue:7
| Neovibsanin F and its congeners, rearranged vibsane-type diterpenes from Viburnum suspensum. |
AID1471418 | Inhibition of HSP90 in rabbit reticulocyte lysate assessed as decrease in HSP90-dependant refolding of firefly luciferase at 10 uM after 30 mins by luciferase gene based assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471443 | Drug metabolism in deionized water assessed as compound decomposition at 100 degreeC after 10 mins by HPLC analysis relative to control | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471405 | Antiproliferative activity against human MDA-MB-468 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471420 | Antiproliferative activity against human AGS cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471447 | Half life of compound in toluene at 60 degreeC by HPLC analysis | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471425 | Toxicity in 3 days post fertilized zebrafish embryo assessed as changes in embryonic phenotypes at 4 to 16 uM after 12 hrs | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471422 | Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471419 | Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471406 | Antiproliferative activity against human SKBR3 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471416 | Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471412 | Inhibition of FITC-geldanamycin binding to human FLAG-tagged HSP90alpha N-terminal domain | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471423 | Antiproliferative activity against human BT474 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471417 | Antiproliferative activity against human SW480 cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471442 | Half life of compound in toluene at 110 degreeC by HPLC analysis | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471448 | Drug degradation in pH 7.4 PBS at 37 degreeC after 12 hrs by HPLC analysis relative to control | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471413 | Inhibition of FITC-geldanamycin binding to human FLAG-tagged HSP90beta N-terminal domain | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID378023 | Toxicity in brine shrimp | 2006 | Journal of natural products, Jul, Volume: 69, Issue:7
| Neovibsanin F and its congeners, rearranged vibsane-type diterpenes from Viburnum suspensum. |
AID1471444 | Stability of compound in boiling ethyl alcohol by HPLC analysis | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
AID1471424 | Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTT assay | 2017 | Journal of medicinal chemistry, 11-09, Volume: 60, Issue:21
| Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |